[Windows 10 1703 download iso itarget apply

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Ask a new question. Was this reply helpful? Yes No. Sorry this didn’t help. Thanks for your feedback. Thanks, I windows 10 1703 download iso itarget apply the download from windowsiso. Any suggestions on checking windowsiso.

Since you already download the ISO file, we would like to request an update if you still need assistance with your concern on how you can verify the legitimacy of the ISO file that you downloaded from a 3rd party website?

The link that was provided by Andre Da Costa in the previous post also contains methods on how you can verify the authenticity of the ISO file that you downloaded. Yes, I downloaded it but have not used it as I was hoping to verify that читать статью is an official Microsoft release. I went to windowsiso. Http://replace.me/19343.txt wasn’t sure how to verify the ISO using Andre Da Windows 10 1703 download iso itarget apply instructions so i f you could help me verify the authenticity of the file it would be greatly appreciated!

There is no need to re-register or create a смотрите подробнее account. If you’re already using Microsoft account, we suggest that you use that account to sign into the MSDN forums and get the direct links to the different ISO’ as well as find information on how to check if the ISO file you have is good to use.

Thanks Jordan, Yes I could sign into the MSDN forums, but after an exhaustive search still could not find any download links for any windows 10 iso windows 10 1703 download iso itarget apply, especially Version that I want to download. Thanks for the update of the current status of your concern. Since the issue still persists and you were not able to get the links for the ISO files, we suggest that you follow the steps posted by Andre Da Windows 10 1703 download iso itarget apply on this thread to use the media creation tool to create an installation media with the specific version of Windows windows 10 1703 download iso itarget apply you would like.

The post has been marked as to have assisted in resolving concerns by our community members. Choose where you want to search below Search Search the Community. Search the community and support articles Windows Windows 10 Search Community member.

Ron – LynnSwerdfeger. Thanks, Ron. This thread is locked. You can follow the question or vote as helpful, but you cannot reply to this thread. I have the same question Report abuse. Details required :. Cancel Submit. Previous Next. Andre Da Costa Volunteer Moderator. How satisfied are you with this reply? Thanks for your feedback, it helps us improve the site. In страница to Andre Da Costa’s post on October 19, Thanks so much for all your assistance!

Jordan Dom Microsoft Agent. In reply to Ron – LynnSwerdfeger’s post on October 19, Hi Ron, Since windows pro 21h1 iso download already download the ISO file, we would like to request an update if you still need assistance with your concern on how you can verify the legitimacy of the ISO file that you downloaded from a 3rd party website?

Feel free to reach out to use for источник concerns. In reply to Jordan Dom’s post on October 25, Thank, Ron.

In reply to Ron – LynnSwerdfeger’s post on October 25, Thanks, but no success. I don’t have a msdn account so I get redirected to the Visual Studio web site. In reply to Ron – LynnSwerdfeger’s post on October 27, Feel free to reach out to us for any further concerns. In reply to Jordan Dom’s post on October 31, In reply to Ron – LynnSwerdfeger’s post on October 31, This site in other languages x.

 
 

 

How to stop from installing through updates

 

Domain beleggen. Domain combinance. Domain pewcharitabletrusts. Domain pewevents. Domain foxnewsplayer-a. Domain trustmagazine. Domain tods. Domain d Domain ampcid. Domain counter. Domain host Domain save-pa. Domain storagetransfer.

Domain analyticsinsights-pa. Domain tasks-pa. Domain chat-pa. Domain ocsp. United Kingdom. Domain mc. Domain p2-fmc3nojqsrklm-ij4du2vrogzar7lz-if-v6exp3-v4. Domain p2-oamrhqljfgo6w7h4dufebkh6-if-v6exp3-v4. Domain translate. Domain p2-pvovhspzkvosu-sb4wmpz5k2hktd7x-if-v6exp3-v4. Domain scholar.

Domain toolbarqueries. Domain desktop. Domain p2-f43cex5g5gbpo-fnxcxc5j7fnkgzsbi2-unicast3. Here are the main support and deployment features : If you have devices running Windows 10, version or later, you can update them quickly to Windows 10, version 22H2 using an enablement package New Windows 10 release cadence that aligns with the cadence for Windows For brand-new computers with Windows 10 deployment, Task Sequences are the only option.

We will cover all the options in this post. The path must point to an extracted source of an ISO file. You need to point at the top folder where Setup. Also enter valid credentials to join the domain. In the Install Configuration Manager tab, select your Client Package On the State Migration tab, select if you want to capture user settings and files. This is the collection that will receive the Windows 10 upgrade. For testing purposes, we recommend putting only 1 computer to start On the Deployment Settings tab, select the Purpose of the deployment Available will prompt the user to install at the desired time Required will force the deployment at the deadline see Scheduling You cannot change the Make available to the following drop-down since upgrade packages are available to clients only On the Scheduling tab, enter the desired available date and time.

We will leave the default options Review the selected options and complete the wizard Launch the Upgrade Process on a Windows 10 computer Everything is now ready to deploy to our Windows 10 computers. This step should take between minutes depending on the device hardware Windows 10 is getting ready, more minutes and the upgrade will be completed Once completed the SetupComplete.

This step is important to set the task sequence service to the correct state Windows is now ready, all software and settings are preserved. Validate that you are running Windows 10 22H2 Build Launch the Process on a new Windows 10 computer To install the Windows 10 22H2 operating system, the process is fairly the same except to start the deployment. Make sure to run a full synchronization to make sure that the new Windows 10 21H1 is available.

It will be available in the Updates section. Select the Windows 10 20H2 feature update and click Install. If you want an automated process, just make your deployment Required. The installation should take around 30 minutes. Use the Preview button at the bottom to scope it to your need. Select your deployment schedule. Remember that this rule will run automatically and schedule your deployment based on your settings. Set your desired User Experience options Select to create a new deployment package.

This is where the Update file will be downloaded before being copied to the Distribution Point Distribute the update on the desired Distribution Point and complete the wizard Your Servicing Plan is now created. On a computer member of the collection, the update will be available in the software center.

The installation should be quicker than the classic Feature Update It should take around 15 minutes. Microsoft Azure is a set of cloud services to help your organization meet your business challenges. This is where you build, manage, and deploy applications on a massive, global network using your favorite tools and frameworks. Microsoft Intune was and is still one of Azure services to manage your devices.

Endpoint security, device management, and intelligent cloud actions This graph from Microsoft makes a good job explaining it: So to wrap up… before you were accessing the Microsoft Intune portal through Azure, now Microsoft wants you to use the new Endpoint Manager Portal. If you have only cloud-based accounts go ahead and assign licenses to your accounts in the portal. Choose Add domain , and type your custom domain name. Once completed your domain will be listed as Healthy.

The OnMicrosoft domain cannot be removed. Go to Devices. Click on the user that you just created Click on Licenses on the left and then Assignment on the top Select the desired license for your user and click Save at the bottom Also, ensure that Microsoft Intune is selected Customize the Intune Company Portal The Intune company portal is for users to enroll devices and install apps.

A file will download in your browser. CSR file you created previously, click Upload Your certificate is now created and available for download. The certificate is valid for 1 year. You will need to repeat the process of creating a new certificate each year to continue managing iOS devices. Click on Download Ensure that the file is a. PEM and save it to a location on your server. It can be installed on any iOS device having iOS 6 and later.

Click Continue The device will make its initial compliance check. Add your group to the desired deployment option. Go to the Properties tab if you need to modify anything like Assignments. You can also see Deployment statistics on this screen Android Devices We will now do the same step for the Android version of Microsoft Authenticator app. To access the Dashboard, simply select Dashboard on the left pane. For our example, we can quickly see the action point we should focus on.

More Pages to Explore Latest Images. Insights Into Our Insights Feature December 21, , am. Frustration Among Migrants at U. December 20, , am. Catholic Charities Under Siege December 17, , pm. Bucs breaking out pewter alternate uniforms for Sunday’s game vs. Bengals December 15, , am. As is: Photographs of Ontario Place, December 15, , am. The system cannot find the file specified This error occur when the WMI service is corrupt. The service did not respond to the start or control request in a timely fashion.

The network path was either typed incorrectly, does not exist, or the network provider is not currently available Please try retyping the path or contact your network administrator. The trust relationship between this workstation and the primary domain failed. We evaluated its transformation rules in two experiments.

In Experiment 1, we examined our transformation rules for conversational representation in relation to sentence length. Log in with Facebook Log in with Google. Remember me on this computer. Enter the email address you signed up with and we’ll email you a reset link. Need an account? Click here to sign up. Download Free PDF. Siu-Tsen Shen. Guess i have to go back to windows 7 till they stop making us download these beta releases. Currently there are 2 computers, 1 with each and that cannot be upgraded to having downloaded the HP software long ago.

It may be possible to accomplish a similar alteration in non HP computers. FreeBooter Win User. You can defer Windows feature updates up to days this means you can stop fall creators update installation. FreeBooter, Nov 16, TrustMe Win User. Give Windows Update MiniTool a try. TrustMe, Nov 16, You must log in or sign up to reply here. Show Ignored Content. Thema: How to stop from installing through updates. How to stop from installing through updates – Similar Threads – stop installing.

How to you stop a specific update from installing : I have several computers that were effected by the March critical update released on March 9th effecting users printing to copiers. CBCT imaging is used for daily online position verification and couch correction based on bony registration.

At this point in time the library plan approach has been integrated into clinical workflow in some institutions. Advanced adaptive IGRT is allowed whenever an institution has this advanced approach clinically implemented. Having multiple diagnostic image sets fused with the treatment planning CT, facilitates this judgement.

For example if the rectum is completely empty it is unlikely that the target volume will be able to move the full mm in the posterior-inferior direction. If the bladder is empty which is, however, unlikely since the aim for the treatment planning CT is a comfortably filled bladder it is unlikely that the target volume will move the full mm in the anterior- inferior direction.

It should be kept in mind that several studies found that the average bladder volume decreases during the course of treatment. Reducing the margin in one direction implies normally that the margin is increased to the same degree in the contralateral direction. The minimal required margin in anterior-posterior and superior-inferior directions is 5 mm. B : The key difference for an individualized ITV-T compared to the standard margin approach is that pre-treatment imaging, both diagnostic and for treatment planning, is used to assess the range of motion in an individual patient.

A pre-requisite is that these imaging series have different filling status of bladder and rectum. For this purpose a full and empty bladder treatment planning CT can be useful. For patients with a smaller range of motion, a smaller ITV margin can be applied, whereas, in patients with a large range of motion, a margin comparable or larger than that derived from standard motion range may be required.

The ITV-T LR margin is adapted based on the assessed range of motion within the individual patients, keeping in mind the proposed standard motion ranges figure 9. Importantly, the ITV-T does not need to include the whole uterus as seen on an image series with an empty bladder, since with the drinking protocol this situation is not expected during the course of fractionated EBRT. It should be kept in mind though that some studies indicate that the average bladder volume decreases during the course of treatment.

If daily soft tissue verification CBCT is used to monitor the daily uterus position, it is possible to shrink the individualised margins further according to the thresholds defined for re-planning. It also contains any CTV-N. This combined tumour and lymph node related target volume is named ITV This final ITV45 is required for dose reporting.

This margin is considered appropriate when using daily image guidance and daily couch correction according to bony fusion see section 9. Each individual pathologic node will have an individual PTV-N.

If they are not encompassed, a larger margin of e. If MRI is made in the treatment position flat couch and with bladder filling protocol the fusion is usually excellent and MRI can be used for contouring all targets and OAR in the whole cranio-caudal length. Priority should be set at achieving an acceptable match within the pelvis.

In these cases it is preferable to use the anatomy as seen on the treatment planning CT for contouring when moving outside the area of acceptable match. All beams and segments involved in a given part of the treatment must be treated at each fraction. This compensation should only be performed once per week, i. However, all pathological nodes with the features described in section 9. Photon energy of 18 MV is related with increased neutron dose, and therefore lower energies e. These two aspects need to be considered when deciding on photon energy.

In case of large lymph nodes it is possible to escalate the central part of the GTV-N to e. The daily imaging is used for fusion and position verification on bony anatomy. Couch correction must be performed daily before treatment delivery according to the bony fusion between the on-board imaging and the treatment planning CT. Couch alignment to take soft tissue into account such as e. Soft tissue verification evaluation of the position of uterus based on CBCT can be performed, but is not mandatory.

With soft tissue verification it is possible to evaluate if the daily uterus position is significantly different from expected and this knowledge can be used to decide that a new treatment plan would be beneficial.

In case of repeated residual misalignment of more than 5mm despite daily correcting to match on bony anatomy the following procedures should be considered: check if immobilization device is used optimally; consider additional tattoos at the level of L2; consider an additional planning CT scan; a last step would be to consider to expand the PTV margin in the para-aortic region where the residual set-up error persists.

Depending on planning system a helper structure might be necessary e. To ensure that the overall treatment time stays below 50 days 4. To maintain and possibly improve a high level of local control in small and well responding tumours 5. To decrease brachytherapy related morbidity through systematic application of brachytherapy related dose volume constraints.

To reduce vaginal morbidity through dose-de-escalation in the vagina by reduction of vaginal loading in cases with no vaginal involvement.

Figure Analogue scheduling applies for PDR brachytherapy. Concomitant chemotherapy given on the first days of the week also theoretically paves the way for sensitizing more fractions of EBRT in that week, rather than giving chemotherapy on a Friday where the sensitizing effect is expected to vanish during the weekend. There is limited data on the optimal timing of EBRT and concomitant chemotherapy on the actual day where it is given. Centres can use their own schedule.

However, for some patients it may be optimal to give EBRT in the morning and concomitant chemotherapy later in the day to avoid problems with an overhydrated and nauseated patient during EBRT. This should be precisely documented on the standard gynaecologic template in three orientations including the speculum view.

This examination can be supported by volumetric imaging, preferably MRI, which allows for even more precise documentation of the tumour situation at brachytherapy. Essential is the relation of these dimensions of the CTV to the cervical canal, the later location of the tandem, in particular, if the distances to the borders of the later CTV-T HR are symmetrical or asymmetrical compare Fig. Taking these dimensions into account a decision is taken about the method of application, in particular, if it can be only intracavitary or a combination of intracavitary and interstitial application.

The most precise pre-treatment planning is with a tandem and vaginal applicators in place, which are only inserted for treatment planning Petric P. Continuous further development is necessary based on clinical and imaging information and corresponding applicator design Dimopoulos JC.

Supportive treatment such as low molecular weight heparin, antibiotics and analgesics are given according to individual patient needs and institutional practice. The clinical examination is documented by drawings by use of the standard clinical diagram see appendix An MRI compatible applicator is then chosen depending on the anatomical topography of tumour, uterus, cervix and vagina and placed in close contact with the tumour and cervix.

The choice of the applicator type depends on the individual anatomy and the tumour spread at the time of brachytherapy. The choice of applicator type e. Vaginal packing must be performed with gauze to push away the rectum and bladder and to fix the applicator against the cervix. The gauze may be filled with contrast medium as diluted gadolinium, US gel or saline water to distinguish the packing from the vagina.

Alternatively, an individual mould or other customized procedures may be used for fixation of the applicator according to the practice of the participating institution. Important is a fixed geometry of the applicator in relation to the target volume. In-vivo dosimetry by use of detectors can be used according to institutional practice. With sufficient vaginal packing, there is according to available evidence so far no indication of relevant movement of the applicator relative to the CTV or to adjacent OAR.

Additional imaging may be performed, if possible, also for each fraction in case of fractionated HDR treatments or as a constancy check during a PDR course if planned in an individual centre.

Each applicator insertion must be followed by at least one 3D volumetric image preferably MRI and dose planning, while subsequent fractions using the same implant might be applied with the same treatment plan. Only in case of exceptional circumstances and if the contouring for reporting is based on an MRI performed at a time point close to the first implant also the first fraction might be planned without MRI with applicator in situ. In these exceptional cases at least one of the subsequent fractions has to be MRI based then.

Sequences taken parallel to the applicator, i. Marker wires of plastic with saline or solutions of CuSO4 can be used to easy the identification of the source channel and determine any rotation of the applicators Dimopoulos JC. Dose points must be defined directly in the 3D imaging set used for contouring and treatment planning and should not be defined in 2D on the radiographs see below. This uncertainty level can only be reached by an appropriate step-by-step quality assurance program in each center Hellebust TP.

This is usually defined or at least checked during commissioning of applicators and afterloaders. The source path can be related to the outer dimensions of an applicator or to marker wires or other indicators placed inside the applicator.

A usual way is to perform auto-radiographs to visualize the dwell positions. Such commissioning procedure should result in drawings of the essential dimensions or even applicator templates which can be integrated into treatment planning systems.

Appropriate imaging has to be performed, either by reducing the slice thickness, by combining different image orientations e. This includes the overall deviation of the planned dwell position to the finally realized dwell position on an anatomical situation as visualized on the planning MRI or CT.

This includes deviations due to source path definition commissioning , equipment performance constancy checks and the reconstruction process in the treatment planning system. For MRI reconstructions library plans are the optimal method. Fusion of CT to MRI is most often not helpful for applicator reconstruction; as such fusion techniques have to be based on the already reconstructed applicator in both image modalities.

In certain situations the needle reconstruction on MRI is difficult. However, this depends on the individual settings and MRI can also be sufficient, even for complex implantation geometries. In addition, the point of expected dose in a specific organ may be determined and used for in vivo dosimetry for instance if rectal diodes are used optional.

Point A is strictly related to the applicator. When defining the recto-vaginal and bladder reference points the image orientation is essential.

Both points are defined according to the patient coordinate system – on anterior-posterior lines, which are strictly perpendicular to the longitudinal axis of the patient. The location of the PIBS points is estimated best on sagittal image orientations, again taking into account the image orientation to define PIBS on a straight anterior-posterior line perpendicular to the patient axis. Sagittal views showing the vagina at time of EBRT and at brachytherapy with an intracavitary applicator in place.

At the level of the vaginal source, dose points lateral to the rings or ovoids can be defined at 0 mm and 5 mm from the applicator surface. The PIBS vaginal-dose point was defined 2 cm posterior from the Posterior-Inferior Border of the pubic symphysis and for BT at the point of this line where it crosses the applicator tandem. The MRI based target delineation can be reused by superimposition in the process of contouring on CT, if for subsequent fractions of brachytherapy only CT can be used with the applicator in place.

There is no specific DVH constraint known so far for the urethra. The most irradiated-tissue volumes adjacent to the applicator, i. The two panels show the different locations of the 0. By courtesy of Primoz Petric. These values were rounded to 95 Gy and 90 Gy, respectively.

The planning aim dose for the point A is a safety measure. Conformal adaptation of dose to very small target volumes, probably related to contouring uncertainties, should not result in too small brachytherapy contributions. However, suggestions for planning aims and prescribed dose are given, with a clear remark that these constraints are only valid in case subsequent fractions or pulses are always related to the same most exposed volume of this organ.

Taking into account the individual patient case and possibilities in application and dose optimization, deviations of these planning aims are allowed. Deviations from these constraints are only allowed in special cases with detailed explanation.

For OARS there are also two levels with planning aims 5 – 10 Gy lower than the maximum limits for the prescribed dose. The use of implant geometries with interstitial needles in addition to an intracavitary applicator is seen essential for unfavourable topography either larger target volumes or unfavourable relation between target and OARs.

This is usually achieved by certain loading patterns in the intrauterine and vaginal applicator parts. In a stepwise procedure the loading pattern and the dwell times are optimized until the planning aims are fulfilled. The loading and dose contribution from the needles is added to the intracavitary dose distribution. This ensures that the dose levels and dose gradients around the implant geometry stay comparable to intracavitary plans and not interstitial plans, where each applicator has a similar weighting.

This should ensure to avoid hot spots and cold spots in any areas not directly controlled via dose points or dose-volume relations. With the use of combined intracavitary-interstitial applicators, it is possible to increase the width of the 85Gy isodose volume by loading the needles, and it is not necessary to heavily load the vaginal sources. Furthermore, limited size tumours often do not need extensive vaginal loading in order to reach a dose of 85Gy EQD2, since they can be reached mainly by loading the tandem Nkiwane KS.

The major priority when performing vaginal dose de-escalation is to decrease the ICRU recto-vaginal point dose according to the dose planning aim of 65Gy, since this is based on clinical evidence. In the same study by Mohamed et al. In brachytherapy the dosimetric characteristics with sources inside the target volume, the variations and the uncertainties are different from those in EBRT. A PTV-T margin in brachytherapy, selected after implantation of the applicator, may contribute to dose escalation throughout the target.

PTV margins should not be used to compensate for uncertainties in 3D image guided intracavitary brachytherapy Tanderup K. This applies to intracavitary and interstitial brachytherapy in cervix cancer. Internal target motion is considered minimal when the applicator is fixed by an intra-vaginal tamponade. As margins along the longitudinal axis of the tandem have limited impact on the dose throughout the target, longitudinal margins along the axis of the tandem maybe used to compensate for these set up variations.

Addition of margins orthogonal to the tandem axis leads to a dose increase throughout the entire target and are therefore not recommended. Normally a margin of 1cm above the CTVHR is applied for robustness to uncertainties see section The aim is to achieve the planning aims as close as possible. However, if those planning aims can be reached, the dose to the parts cranial to CTV if OAR doses are fullfilled is not decreased to reach a conformal situation.

By this the dose is kept high in a region which is prone to contouring uncertainties and possible systematic uncertainties in the applicator location shifting of the applicator in caudal direction as shown in figure The longitudinal margin can be secured by visual inspection of isodose lines, and it is not required to draw specifically a PTV. Margins are added to compensate for uncertainties only in the longitudinal direction, whereas no margins can be added in the orthogonal direction.

If the node is not covered by the MRI performed for brachytherapy it is assumed that the dose contribution from brachytherapy to such a node is negligible. Rose PG. Other chemotherapeutics and schedules might carefully be considered if monotherapy cisplatin cannot be given due to patient related factors, like co-morbidity or early cisplatinum related morbidity and must be reported. Treatment with Cisplatin should be withheld at the discretion of the center.

Several guidelines on chemo-radiation protocols exist for cisplatin withhold Rose PG. Leucocytes and granulocyte numbers are used as constraints for withhold of cisplatin.

Therefore we suggest to use either leucocyte or granulocyte counts as constraints. Guidelines for withhold vary for leucocytes counts around 2. Cisplatin can be resumed in the next cycle once the blood counts exceed these limits. Cisplatin should be totally discontinued if blood tests remain unacceptable or febrile leucopoenia recurs despite dose reduction.

Haemoglobin should be monitored during treatment. Corrections by transfusion according to institutional guidelines are allowed and have to be reported. Stratification for yes or no adjuvant chemotherapy will be performed for treatment outcome analysis.

Before starting adjuvant chemotherapy the toxicities of the concomitant chemoradiation should be resolved to less than grade 2.